Arovella Therapeutics: Receives $524,000 R&D tax refund

Arovella Therapeutics Receives $524,000 R&D tax refund

• Arovella Therapeutics (ALA) receives a $524,000 tax refund from the Australian Taxation Office
• The refund was returned under the research and development (R&D) tax incentive for the 2021 financial year
• The program recognises Arovella’s R&D work relating to its treatment development for cancer and conditions that affect the central nervous system.
• The company says the return will further support its development work for the current year
• ArovellaTherapeutics last traded grey at 3.8 cents at 3:20 pm AEDT